Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740. Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Next page Next › Last page Last »
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary May 2022 ¿Cómo deberían responder los médicos al interés de los pacientes sobre suplementos dietético para tratar enfermedades crónicas graves? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES AMA J Ethics. 2022;E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740.
Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471.